Phase II Study Evaluating the Interest of the Re-introduction of Pemetrexed and Platinum (Cisplatin or Carboplatin) With Prolonged Angiogenic Blocking by Bevacizumab in Non Squamous Non Small Cell Lung Cancer of Advanced Stage.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bevacizumab; Carboplatin; Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Acronyms BUCiL
- 13 May 2019 Biomarkers information updated
- 18 Jul 2013 Actual initiation date changed from Oct 2012 to Dec 2012 as reported by ClinicalTrials.gov.
- 08 Nov 2012 New trial record